Fuad El-Hibri, Executive Chairman at Emergent BioSolutions Inc. (EBS), sold 120,000 shares at $61.90 ($7.3M) on 2020-02-06, disclosed to the SEC on 2020-02-07.
Open-market sale of $7.3M EBS by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.66 | 48,316 | $2.9M | 40.1% |
| 2 | $60.66 | 48,316 | $2.9M | 40.1% |
| 3 | $61.90 | 11,684 | $723K | 9.9% |
| 4 | $61.90 | 11,684 | $723K | 9.9% |
| Total | $60.90 avg | 120,000 | $7.3M | 100% |
| Filing → |
| EBS | SELL | 2020-09-25 | $3.8M | — | Filing → |
| EBS | SELL | 2020-09-18 | $6.1M | — | Filing → |
| EBS | SELL | 2020-09-11 | $4.1M | — | Filing → |